Aerosol release, distribution, and prevention during aerosol therapy: a simulated model for infection control. (31st December 2022)

• Record Type: Journal Article
• Authors: Mac Giolla Eain, Marc; Cahill, Ronan; MacLoughlin, Ronan; Nolan, Kevin
• Is Part Of: Drug delivery. Volume 29:Number 1(2022)
• Page Start: 10
• Page End: 17
• Publication Date: 2022-12-31
• Subjects: COVID-19 -- aerosol therapy -- viral infections -- vibrating mesh nebulizer -- fugitive emissions -- Schlieren imaging -- aerosol visualization; Drug delivery systems -- Periodicals; Drug targeting -- Periodicals; 615.05
• DOI: 10.1080/10717544.2021.2015482
• Languages: English
• ISSNs: 1071-7544

Abstract

Abstract: Aerosol therapy is used to deliver medical therapeutics directly to the airways to treat respiratory conditions. A potential consequence of this form of treatment is the release of fugitive aerosols, both patient derived and medical, into the environment and the subsequent exposure of caregivers and bystanders to potential viral infections. This study examined the release of these fugitive aerosols during a standard aerosol therapy to a simulated adult patient. An aerosol holding chamber and mouthpiece were connected to a representative head model and breathing simulator. A combination of laser and Schlieren imaging was used to non-invasively visualize the release and dispersion of fugitive aerosol particles. Time-varying aerosol particle number concentrations and size distributions were measured with optical particle sizers at clinically relevant positions to the simulated patient. The influence of breathing pattern, normal and distressed, supplemental air flow, at 0.2 and 6 LPM, and the addition of a bacterial filter to the exhalation port of the mouthpiece were assessed. Images showed large quantities of fugitive aerosols emitted from the unfiltered mouthpiece. The images and particle counter data show that the addition of a bacterial filter limited the release of these fugitive aerosols, with the peak fugitive aerosol concentrations decreasing by 47.3–83.3%, depending on distance from the simulated patient. The addition of a bacterial filter to the mouthpiece significantly reduces the levels of fugitive aerosols emitted during a simulated aerosol therapy, p ≤ .05, and would greatly aid in reducing healthcare worker and bystander exposure to potentially harmful fugitive aerosols.